380 related articles for article (PubMed ID: 15734999)
1. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.
Asatiani E; Huang WX; Wang A; Rodriguez Ortner E; Cavalli LR; Haddad BR; Gelmann EP
Cancer Res; 2005 Feb; 65(4):1164-73. PubMed ID: 15734999
[TBL] [Abstract][Full Text] [Related]
2. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.
Bowen C; Bubendorf L; Voeller HJ; Slack R; Willi N; Sauter G; Gasser TC; Koivisto P; Lack EE; Kononen J; Kallioniemi OP; Gelmann EP
Cancer Res; 2000 Nov; 60(21):6111-5. PubMed ID: 11085535
[TBL] [Abstract][Full Text] [Related]
3. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
Xu LL; Srikantan V; Sesterhenn IA; Augustus M; Dean R; Moul JW; Carter KC; Srivastava S
J Urol; 2000 Mar; 163(3):972-9. PubMed ID: 10688034
[TBL] [Abstract][Full Text] [Related]
4. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
[TBL] [Abstract][Full Text] [Related]
5. Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers.
Voeller HJ; Augustus M; Madike V; Bova GS; Carter KC; Gelmann EP
Cancer Res; 1997 Oct; 57(20):4455-9. PubMed ID: 9377551
[TBL] [Abstract][Full Text] [Related]
6. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer.
He WW; Sciavolino PJ; Wing J; Augustus M; Hudson P; Meissner PS; Curtis RT; Shell BK; Bostwick DG; Tindall DJ; Gelmann EP; Abate-Shen C; Carter KC
Genomics; 1997 Jul; 43(1):69-77. PubMed ID: 9226374
[TBL] [Abstract][Full Text] [Related]
7. Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesis.
Korkmaz CG; Korkmaz KS; Manola J; Xi Z; Risberg B; Danielsen H; Kung J; Sellers WR; Loda M; Saatcioglu F
J Urol; 2004 Sep; 172(3):1134-9. PubMed ID: 15311057
[TBL] [Abstract][Full Text] [Related]
8. [The specific expression profile of homeobox gene NKX3.1 mRNA and protein in prostate tissues and its relationship with primary prostate cancer].
Yang GS; Wang YM; Chen ZD
Zhonghua Nan Ke Xue; 2006 Feb; 12(2):137-40, 144. PubMed ID: 16519150
[TBL] [Abstract][Full Text] [Related]
9. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer.
Chen C; Bhalala HV; Vessella RL; Dong JT
Prostate; 2003 May; 55(2):81-8. PubMed ID: 12661032
[TBL] [Abstract][Full Text] [Related]
10. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis.
Ouyang X; DeWeese TL; Nelson WG; Abate-Shen C
Cancer Res; 2005 Aug; 65(15):6773-9. PubMed ID: 16061659
[TBL] [Abstract][Full Text] [Related]
11. Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer.
Wang J; Thompson B; Ren C; Ittmann M; Kwabi-Addo B
Prostate; 2006 May; 66(6):613-24. PubMed ID: 16388505
[TBL] [Abstract][Full Text] [Related]
12. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis.
Kim MJ; Bhatia-Gaur R; Banach-Petrosky WA; Desai N; Wang Y; Hayward SW; Cunha GR; Cardiff RD; Shen MM; Abate-Shen C
Cancer Res; 2002 Jun; 62(11):2999-3004. PubMed ID: 12036903
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1.
Abdulkadir SA
Ann N Y Acad Sci; 2005 Nov; 1059():33-40. PubMed ID: 16382041
[TBL] [Abstract][Full Text] [Related]
14. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
16. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
Thomas MA; Preece DM; Bentel JM
Biochem J; 2010 Jan; 425(3):575-83. PubMed ID: 19886863
[TBL] [Abstract][Full Text] [Related]
17. Functional epigenomics identifies genes frequently silenced in prostate cancer.
Lodygin D; Epanchintsev A; Menssen A; Diebold J; Hermeking H
Cancer Res; 2005 May; 65(10):4218-27. PubMed ID: 15899813
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of NKX3.1 in LNCaP prostate cancer cells by RNA interference.
Possner M; Heuser M; Kaulfuss S; Scharf JG; Schulz W; Hermann-Ringert R; Thelen P
Int J Oncol; 2008 Apr; 32(4):877-84. PubMed ID: 18360715
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the ASC gene promoter is associated with aggressive prostate cancer.
Collard RL; Harya NS; Monzon FA; Maier CE; O'Keefe DS
Prostate; 2006 May; 66(7):687-95. PubMed ID: 16425203
[TBL] [Abstract][Full Text] [Related]
20. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
Kang GH; Lee S; Lee HJ; Hwang KS
J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
